Aries Agro Limited Overview
Aries Agro is one of India's longest-established specialty plant-nutrition companies and a pioneer of chelated micronutrient fertilisers in the country, having introduced the Agromin chelated micronutrient mixture in 1975 and Chelamin chelated zinc in 1976. It is a promoter-controlled micro-cap (Mirchandani family 52.66%) whose business is almost entirely domestic, dealer-distributed, highly seasonal, and working-capital intensive. Its product basket spans chelated and non-chelated micronutrients, secondary nutrients (sulphur, calcium, magnesium), water-soluble and specialty fertilisers, bio-stimulant-type plant-health products, and a small but fast-growing farm-equipment/pest-trap line. CRISIL (January 2022) estimated the group's share of the organised domestic chelated-micronutrient market at roughly 30%, making it the category leader. After a decade of stagnant returns, FY2025–FY2026 marked an inflection: consolidated revenue grew ~19–20% per year, PAT more than doubled over two years, net debt fell to near zero, and the working-capital cycle compressed sharply — catalysing a re-rating of the stock.
What the company does
Aries Agro manufactures, imports, formulates and markets micronutrients and other customised nutritional products, principally for plants and historically also for animals (the company's origin was mineral feed additives for livestock and poultry). Today, the plant-nutrition business dominates: the company reports a single operating segment labelled "Micronutrient Fertilizers" in its exchange filings (iXBRL, Q2 FY2026).
The product range covers:
Micronutrients: zinc, iron, manganese, copper, boron, molybdenum, in chelated (EDTA-type metal chelates) and non-chelated forms, both single-element and multi-nutrient mixtures (flagships Agromin and Chelamin).
Secondary nutrients: sulphur, magnesium and calcium (added 2001), including sulphur bentonite and sulphur-based pastillated products manufactured in the UAE.
Specialty and water-soluble nutrition: crop-specific formulations (e.g., Majorsol Soybean & Pulses Special), concentrated liquid micronutrients (Zinc HD Gold, Agromin Max HD), calcium–magnesium sources (Calmax), silicon (Aries Silica).
Plant-health / immunity / bio-inputs: Aries Ecoshield (plant immunity booster), bio-fertilisers (entered with the Ahmedabad unit in 2008).
Agri-equipment and IPM devices: via subsidiary Aries Agro Equipments Pvt Ltd (e.g., Magic Traps, Aries Trap X, Aries Suraksha) and soil-management technology (Aries Soil Wrap).
The company also maintains exclusive marketing arrangements with overseas plant-nutrition manufacturers (Europe, Turkey, Singapore, USA, South America), adapting imported products to Indian conditions — a "Made for India" positioning it has long used (company profile).
Business and revenue model
| Dimension | Characterisation |
|---|---|
| Revenue model | Almost entirely product sales (manufactured and traded fertiliser products). No meaningful service, subscription or licensing revenue disclosed. |
| Channel | Business-to-business-to-farmer: sales to dealers/distributors who extend credit to retailers and farmers. FY2026 annual booking involved 1,717 dealers across 26 states (Board's Report FY2025). |
| Demand-booking mechanism | An annual "booking bazaar" / online booking app where dealers place forward bookings for the year: INR 835.10 cr booked for FY2025 and INR 830.44 cr for FY2026 (MD&A FY2025; Board's Report FY2025). |
| Gross-to-net | Significant trade discounts/rebates: consolidated FY2025 gross revenue INR 804.59 cr vs. net revenue INR 622.22 cr (discounts ~INR 182 cr, ~22.6% of gross). FY2026 gross INR 956.88 cr vs. net INR 740.06 cr. |
| Seasonality | Strong concentration in Q2 (kharif) and Q3 (rabi); Q4 is structurally weak and frequently loss-making (Q4 FY2026 consolidated loss of INR 4.79 cr). Management explicitly flags cropping patterns, seasonality and weather as drivers (Q1 FY2027 press release). |
| Value-chain position | Mid-stream formulator/manufacturer: imports or buys metal salts, chelating agents, sulphur, etc.; formulates, packages and brands; relies heavily on field-extension marketing (3,958 farmer meetings reaching 54,948 farmers in FY2026). |
| Customers | Dealers/distributors (direct customers); end users are farmers — field crops (cereals, pulses, oilseeds, sugarcane) and high-value horticulture (grapes, potatoes, mangoes, vegetables). Institutional/government sales: not separately disclosed. |
| End-markets | Indian agriculture overwhelmingly; limited exports/overseas sales via the UAE subsidiary (Golden Harvest Middle East FZC) and associate (Amarak Chemicals FZC). |
Company's own description vs. independent characterisation
Company's description (paraphrased from FY2026 press release and FY2025 Annual Report): Aries describes itself as one of India's leading plant-nutrition and specialty agri-input companies with a 57-year legacy, deep farmer connections, a diversified product portfolio and an innovation-led approach, aiming to become a globally competitive agri-nutrition enterprise.
Independent characterisation: Aries is a niche, promoter-run, India-centric specialty fertiliser formulator that is unsubsidised (micronutrients sit outside India's Nutrient Based Subsidy regime for primary fertilisers), brand- and extension-driven, and historically constrained by a very long cash-conversion cycle and thin net margins (3–4%). The FY2025–FY2026 improvement appears driven by operating leverage, lower interest costs from deleveraging, and much tighter receivables management rather than by a structural change in the business model. It remains small (FY2026 net revenue ~INR 740 cr, ~USD 85–90 m) relative to diversified fertiliser majors that also sell micronutrients.
Strategy
Stated strategic themes (paraphrased from FY2026 press release, FY2025 Annual Report and October 2026 company-sourced coverage)
-
Innovation-led specialty nutrition — continued launches of concentrated (HD), crop-specific and plant-health products (FY2025: Ecoshield, Majorsol, Calmax, Zinc HD Gold; FY2026: Trillion, Silica, Agromin Max HD).
-
Farmer-centric extension marketing — meetings, Kisan Melas and partnerships with grower associations (Punjab potato, Maharashtra mango, Karnataka GKVK).
-
Operational and working-capital discipline — explicit targets/achievements on inventory days (60 → 55) and receivable days (53 → 35), working-capital cycle 89 → 64 days.
-
Manufacturing expansion and modernisation — capacity to 101,400 MT p.a., automation at Vijayawada and Nashik, owned-premises relocation in UP.
-
Distribution deepening — depot network expanded to 30.
-
Digitalisation — booking app, AIMS ERP, Aries Everywhere field monitoring, digitised Magic Traps; MoU with Jio (c. 2024).
-
Brand building — Sourav Ganguly as brand ambassador (3 years from Mar 2026); mascot "Jeevan".
-
Long-term aspiration — to become a globally competitive, sustainable agri-nutrition enterprise.
Initiative register (last 24 months)
| Date | Initiative | Type | Detail |
|---|---|---|---|
| FY2025 | New products (Ecoshield, Majorsol Soybean & Pulses Special, Calmax, Zinc HD Gold) | Product | MD&A FY2025 |
| FY2025 | Groundbreaking of new Lucknow-area facility; Vijayawada office expansion | Footprint | IIFL summary |
| Sep 2024–Feb 2025 | Farmer events (Kartarpur, GKVK Bangalore, Vishaka Organic Mela, Mumbai mango growers) and IMMA B2B conclave at BSE (8 Feb 2025) | Marketing / partnerships | MD&A FY2025 |
| Aug 2025 (for FY2026) | Online annual booking: INR 830.44 cr from 1,717 dealers; company aimed for ~INR 950 cr in FY2026 | Commercial | Board's Report FY2025 |
| 12 Feb 2026 | Sayakha plant (+6,000 MT p.a.) | Capacity | Reg. 30 |
| 5 Mar 2026 | Unnao relocated plant (~INR 12 cr, internal accruals) | Footprint | Reg. 30 |
| 30 Mar 2026 | Sourav Ganguly brand ambassador | Brand | Exchange disclosure |
| FY2026 | 30 depots; automation at Vijayawada and Nashik; launch of Trillion, Silica, Agromin Max HD, Suraksha, Trap X, Soil Wrap | Distribution / product | Global Agriculture, Oct 2026 |
| May 2026 | Special dividend INR 1 per share | Capital allocation | Board, 28 May 2026 |
Medium-term guidance / targets
Management does not publish formal financial guidance. The only quantitative forward indicators found are the annual dealer booking (INR 830.44 cr for FY2026) and an implied FY2026 revenue aspiration of ~INR 950 cr (Board's Report FY2025), against which actual standalone gross revenue was INR 917.64 cr and consolidated gross INR 956.88 cr. ESG or cost-programme targets: not publicly disclosed.
Products & Services
Aries does not publish revenue by product. The catalog below lists all products and brands identified in filings, chairman's speeches, MD&A and company-sourced media; launch years given where disclosed. Pricing models are not disclosed (products are sold at dealer price lists with trade discounts).
Micronutrients (core)
| Brand / product | Description | Target customer / crop | Launch | Source |
|---|---|---|---|---|
| Agromin | Chelated multi-micronutrient fertiliser; India's first chelated micronutrient product | Broad-acre and horticulture farmers | 1,975 | Company profile |
| Chelamin | Chelated zinc | Zinc-deficient soils (rice, wheat, maize) | 1,976 | Company profile |
| Agromin Max HD | High-density / concentrated variant of Agromin | Farmers seeking lower application volumes | FY2026 | Global Agriculture, Oct 2026 |
| Zinc HD Gold | Concentrated liquid zinc | Foliar application | FY2025 | MD&A FY2025 |
| Grapemin | Crop-specific micronutrient mix for grapes | Grape growers (Maharashtra) | c. 2024 (n.v.) | ROIC.ai summary |
| High-density fertiliser range | New "HD" concentrated formulations | — | c. 2024 | ROIC.ai summary |
| Soluble boron | Water-soluble boron | Oilseeds, fruits, vegetables | Manufactured in UAE from 2011 | Company history |
Secondary nutrients
| Product | Description | Launch | Source |
|---|---|---|---|
| Sulphur, magnesium, calcium range | Secondary nutrient fertilisers | 2,001 | Company profile |
| Sulphur bentonite | Slow-release elemental sulphur | UAE production 2011 | Company history |
| Sulphur-based pastillated products (four products) | Value-added sulphur pastilles for India and export | Fujairah restart Sep 2021 | Chairman's speech 2022 |
| Calmax | Plant-based source of calcium and magnesium | FY2025 | MD&A FY2025 |
Specialty, crop-specific and biostimulant-type products
| Product | Description | Launch | Source |
|---|---|---|---|
| Majorsol Soybean & Pulses Special | Crop-specific specialty nutrition for growth and seed set | FY2025 | MD&A FY2025 |
| Aries Ecoshield | Plant immunity booster | FY2025 | MD&A FY2025 |
| Aries Trillion | New plant-nutrition product (specification n.d.) | FY2026 | Global Agriculture, Oct 2026 |
| Aries Silica | Silicon-based crop input | FY2026 | Global Agriculture, Oct 2026 |
| Bio-fertilisers range | Biological fertilisers | 2008 (Ahmedabad unit) | Company history |
| Organic farming solutions | Showcased at organic melas | 2,024 | MD&A FY2025 |
Agri-equipment, IPM and soil technology (Aries Agro Equipments Pvt Ltd)
| Product | Description | Launch | Source |
|---|---|---|---|
| Magic Traps | Pest traps; digitisation programme highlighted | Pre-FY2025 | MD&A FY2025 |
| Aries Trap X | Pest trap | FY2026 | Global Agriculture, Oct 2026 |
| Aries Suraksha | Agricultural equipment / protective product (spec. n.d.) | FY2026 | Global Agriculture, Oct 2026 |
| Aries Soil Wrap | Soil-management (mulch-type) technology | FY2026 | Global Agriculture, Oct 2026 |
| Imported farm equipment | Trading of farm equipment | Ongoing | CRISIL rationale |
Animal nutrition (legacy)
Mineral premixes, milk boosters, protein concentrates, vitamin premixes and feed additives formed the company's original business. Current revenue contribution is not publicly disclosed; the reported single segment is "Micronutrient Fertilizers".
Digital and farmer-engagement platforms (non-revenue)
| Platform | Function | Source |
|---|---|---|
| Aries booking app | Online annual dealer booking (1,717 dealers, 26 states for FY2026) | Board's Report FY2025 |
| AIMS – Aries Integrated Management System | Internal ERP/management platform | MD&A FY2025 |
| Aries Everywhere | Sales and field-activity monitoring | MD&A FY2025 |
| Kisan Melas / farmer meetings | 3,958 meetings, 54,948 farmers reached in FY2026 | Global Agriculture, Oct 2026 |
Financial Narrative
All figures consolidated, INR cr, fiscal years ending 31 March. Primary sources: audited results filings (FY2025, FY2026), FY2026 press release; supplemented by StockAnalysis, TipRanks, Anand Rathi and Tapetide for earlier years. EBITDA is the company's/aggregator "operating profit" definition (matches the company's FY2025–FY2026 press-release EBITDA).
Income statement
Notes: (1) EPS is on profit attributable to owners (e.g., FY2025 INR 34.0 cr; FY2026 INR 42.85 cr). (2) FY2026 DPS: a special dividend of INR 1.00 is confirmed (board, 28 May 2026); the total of INR 2.50 (implying a final of INR 1.50) is from an aggregator (DivvyDiary) and should be confirmed against the AGM notice. (3) Dividend shown against the fiscal year to which it relates. (4) Minor discrepancies: Screener shows FY2025 PBT INR 44 cr and interest INR 19 cr; TipRanks shows FY2025 EBITDA INR 72.3 cr (consistent).
Margin profile
Revenue CAGR FY2022–FY2026: ~14.4% (net revenue, consolidated). PAT CAGR FY2022–FY2026: ~34.5%.
Commentary. The P&L shows two distinct regimes. FY2022–FY2024 was a low-growth, high-interest period: revenue compounded ~9%, gross margins fell sharply in FY2023 (raw-material inflation and supply-chain volatility), and finance costs absorbed ~40% of EBIT, keeping net margins near 3–3.6%. FY2025–FY2026 is the inflection: revenue accelerated to ~19–20% p.a., interest cost fell ~19% in FY2025 as debt was repaid, and PBT margin widened ~260 bp over two years. Importantly, gross margin has declined (43.0% → 40.4%) over FY2024–FY2026, implying growth has come with a richer share of lower-margin or traded products, heavier discounts, or input-cost pass-through lags; the EBITDA margin has been held only through operating leverage on selling and administrative costs. Below-the-line, FY2026 benefited from INR 12.7 cr of other non-operating income (StockAnalysis), which contributed to the 36% PBT growth — a quality-of-earnings point to monitor.
Quarterly profile (consolidated, INR cr)
Q2 FY2026 revenue derived as FY2026 total less the other three quarters. Q1 FY2027: owners' share of PAT INR 14.91 cr (+48.7% YoY); standalone net revenue INR 180.83 cr (+17.3%). PTI reported "total revenue" of INR 237.05 cr — this appears to be a gross figure before discounts; the company's net figure is INR 185.86 cr. Aggregator figures of INR 185–188 cr differ marginally due to rounding/other income.
Balance sheet (consolidated, INR cr, 31 March)
Notes: Balance-sheet line items from StockAnalysis (INR million converted); total borrowings derived as net debt + cash and corroborated by Tapetide (112/100/74/49/56). Goodwill: none disclosed. Book value per share: Bajaj Broking publishes two series without labelling standalone vs consolidated; both are shown. Derived equity on Basis A: ~INR 211 cr (FY2022) rising to ~INR 290 cr (FY2026).
Commentary. The balance sheet has de-risked materially. Net debt fell from INR 112 cr (FY2022) to INR 7 cr (FY2026), and the company now holds ~INR 49 cr of cash and short-term investments. The FY2026 decline in receivables (INR 118 cr → INR 93 cr) despite ~19% revenue growth is the single most notable balance-sheet development and supports the company's claim that receivable days fell from 53 to 35. PP&E has more than doubled since FY2022 (Hyderabad Phase 3, Raipur, Chhatral, Sayakha, Unnao), indicating the company is in an investment phase financed largely from internal accruals. Long-term investments (~INR 65 cr) likely include the UAE associate and other strategic holdings; their recoverability is a diligence point.
Cash flow (consolidated, INR cr)
Sources: Tapetide (FCF series); share.market (FY2026 cash-flow statement).
Commentary. Aries has generated positive FCF in every year shown, averaging ~INR 52 cr p.a. — high relative to reported PAT, reflecting non-cash charges and working-capital release. FY2026 FCF fell to ~INR 38 cr because capex stepped up to ~INR 48 cr (Sayakha, Unnao relocation, automation at Vijayawada and Nashik) and the company parked ~INR 19 cr in short-term investments (investing outflow of INR 77.7 cr includes treasury placements).
Ratios
Notes: ROE and D/E use Basis A equity (see 6.4) and are approximations. Screener reports a 3-year average ROE of 9.25% (through FY2025), consistent with the approximations above.
Overall financial verdict. The company has moved from a leveraged, low-return, working-capital-trapped business (ROE ~6–8%) to a near-debt-free business earning mid-teens ROE. Sustainability depends on (a) holding receivable discipline through a weak monsoon year, (b) arresting gross-margin erosion, and (c) earning a return on the expanded fixed-asset base at ~72% capacity utilisation.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment
| Segment | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Micronutrient Fertilizers revenue (INR Cr) | 516.46 | 622.22 | 740.06 |
Micronutrient Fertilizers PBT (INR Cr) | 28.38 | 44.39 | 60.29 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansSegment Margins & Growth (%) and Revenue by Segment (%)
| Segment metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
YoY revenue growth (%) | 9.4 | 20.5 | 18.9 |
PBT margin on net revenue (%) | 5.5 | 7.1 | 8.1 |
Share of total revenue (%) | 100 | 100 | 100 |
Revenue by Segment — Gross revenue from operations
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Gross revenue from operations (INR Cr) | 672.86 | 804.59 | 956.88 |
Discounts and rebates (INR Cr) | 156.40 | 182.18 | 216.82 |
Net revenue from operations (INR Cr) | 516.46 | 622.22 | 740.06 |
Group Entities
| Entity | Relationship | Country | Activity | Notes |
|---|---|---|---|---|
Mirabelle Agro Manufacturing Pvt Ltd | Wholly owned subsidiary | India (Chhatral, Gujarat) | Manufacturing | Incorporated 26 Dec 2019; FY2026 revenue growth 48.98% |
Aries Agro Equipments Pvt Ltd | Wholly owned subsidiary | India | Import and trading of farm equipment, traps | FY2026 revenue growth 91.81% |
Golden Harvest Middle East FZC | Subsidiary (75% acquired 2008; current stake n.v.) | UAE (Sharjah/Fujairah) | Manufacturing of chelates, soluble boron, sulphur products | Likely the non-wholly-owned subsidiary given non-controlling-interest losses (inference) |
Amarak Chemicals FZC | Associate (49% via Golden Harvest) | UAE | Chemicals manufacturing | Reportedly commenced operations at a facility in Feb 2026 (details n.v.) |
Aries Agro Care Pvt Ltd | Former subsidiary (seeds trading) | India | — | Listed in CRISIL 2024 rationale; current status n.v. |
Aries Agro Produce Pvt Ltd | Former subsidiary | India | — | Appeared in older annual reports; current status n.v. |
Segment Revenue
| Metric | Standalone | Consolidated |
|---|---|---|
Net revenue from operations | 701.83 | 740.06 |
Gross revenue | 917.64 | 956.88 |
PBT | 53.45 | 60.29 |
PAT | 38.37 | 42.37 |
Q4 FY2026 PAT | -3.48 | -4.79 |
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Net revenue from operations (INR Cr) | 432.4 | 472.2 | 516.5 | 622.2 | 740.1 |
Total income incl. other income (INR Cr) | 443.9 | 481.1 | 519.4 | 627.1 | 752.8 |
Gross profit (INR Cr) | 200.9 | 192.9 | 222.3 | 259.1 | 298.9 |
EBITDA (INR Cr) | 50.5 | 56.6 | 58.4 | 72.3 | 88.9 |
Operating income / EBIT (INR Cr) | 41.0 | 39.9 | 47.7 | 57.8 | 65.3 |
Interest expense (INR Cr) | 23.3 | 21.7 | 21.3 | 17.4 | 17.7 |
Profit before tax (INR Cr) | 20.3 | 25.4 | 28.4 | 44.4 | 60.3 |
Net income / PAT (INR Cr) | 12.9 | 15.9 | 18.4 | 33.5 | 42.4 |
EPS basic and diluted (INR) | 10.22 | 13.17 | 14.94 | 26.16 | 32.95 |
Dividend per share (INR) | 0.80 | 1.00 | 1.00 | 1.20 | 2.50 |
Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Gross margin (%) | 46.5 | 40.9 | 43.0 | 41.6 | 40.4 |
EBITDA margin on net revenue (%) | 11.7 | 12.0 | 11.3 | 11.6 | 12.0 |
Operating (EBIT) margin (%) | 9.5 | 8.5 | 9.2 | 9.3 | 8.8 |
PBT margin (%) | 4.7 | 5.4 | 5.5 | 7.1 | 8.1 |
Net margin (%) | 3.0 | 3.4 | 3.6 | 5.4 | 5.7 |
Revenue growth YoY (%) | 13.3 | 9.2 | 9.4 | 20.5 | 18.9 |
Revenue History
| Quarter | Net revenue | PBT | PAT |
|---|---|---|---|
Q1 FY2026 (Jun 2025) | 159.79 | n.v. | 9.93 |
Q2 FY2026 (Sep 2025) | 200.11 (derived) | 28.05 | 19.92 |
Q3 FY2026 (Dec 2025) | 200.94 | 23.84 | 17.31 |
Q4 FY2026 (Mar 2026) | 179.22 | -6.10 | -4.79 |
FY2026 total | 740.06 | 60.29 | 42.37 |
Q1 FY2027 (Jun 2026) | 185.86 | 19.62 | 14.85 |
Balance Sheet and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (INR Cr) | 509.0 | 519.8 | 517.5 | 581.4 | 638.8 |
Cash and short-term investments (INR Cr) | 0.7 | 1.9 | 2.4 | 30.7 | 48.7 |
Total borrowings (INR Cr) | 112.3 | 99.7 | 73.6 | 48.6 | 55.7 |
Net debt (INR Cr) | 111.6 | 97.8 | 71.1 | 17.9 | 7.1 |
Trade receivables (INR Cr) | 118.6 | 118.4 | 113.4 | 117.9 | 92.8 |
Inventory (INR Cr) | 147.1 | 143.9 | 126.4 | 132.8 | 143.9 |
Property, plant and equipment (INR Cr) | 67.6 | 75.0 | 97.6 | 119.4 | 156.2 |
Long-term investments (INR Cr) | 57.5 | 62.3 | 63.2 | 64.8 | 64.8 |
Intangible assets (INR Cr) | 0.13 | 0.12 | 0.11 | 0.11 | 0.39 |
Book value per share, Basis A (INR) | 161.92 | 172.44 | 186.75 | 200.20 | 222.68 |
Book value per share, Basis B (INR) | 146.51 | 160.45 | 174.91 | 190.54 | 211.09 |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Free cash flow (INR Cr) | 63 | 39 | 46 | 74 | 38 |
Metric (FY2026 only, INR Cr) | Value | — | — | — | — |
Operating cash flow | 86.08 | — | — | — | — |
Investing cash flow | -77.72 | — | — | — | — |
Financing cash flow | -12.18 | — | — | — | — |
Net change in cash | -3.82 | — | — | — | — |
Implied capex (OCF − FCF) | ~48 | — | — | — | — |
Dividends paid (FY2025 dividend of INR 1.20 × 13.0 m shares) | ~1.6 | — | — | — | — |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE on average equity, Basis A (%) | 6.3 | 7.3 | 7.9 | 13.3 | 15.4 |
ROA (PAT / year-end total assets, %) | 2.5 | 3.1 | 3.6 | 5.8 | 6.6 |
Debt to equity, Basis A (x) | 0.53 | 0.44 | 0.30 | 0.19 | 0.19 |
Net debt to EBITDA (x) | 2.21 | 1.73 | 1.22 | 0.25 | 0.08 |
Interest coverage, EBITDA / interest (x) | 2.17 | 2.60 | 2.74 | 4.16 | 5.01 |
Asset turnover (x) | 0.85 | 0.91 | 1.00 | 1.07 | 1.16 |
Cash conversion cycle, aggregator (days) | 224 | 212 | 191 | 159 | 115 |
Region Overview
| Region | Evidence | Revenue share |
|---|---|---|
India | Dealer base of 1,717 dealers across 26 states; 30 depots; nine Indian manufacturing/packing sites | Not disclosed; estimated to be the substantial majority |
UAE / Middle East / export | Golden Harvest Middle East and associate Amarak Chemicals manufacture sulphur and chelated products "for sale in India and globally" | — |
“—” = not publicly disclosed.
Geographic Revenue
| Region | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Total (all geographies, consolidated) | 516.46 | 622.22 | 740.06 |
Standalone (India parent) | 507.65 | 597.65 | 701.83 |
Valuation Snapshot
| Metric | Value | Date | Source |
|---|---|---|---|
Last price (NSE) | INR 479.90 | 14 Oct 2026 | IIFL |
Market cap | ~INR 624 cr | 14 Oct 2026 | IIFL |
52-week range | INR 285.35 – 524.75 | 14 Oct 2026 | IIFL |
P/E (TTM) | 14.6x | 14 Oct 2026 | IIFL |
P/B | 2.0x | 14 Oct 2026 | IIFL |
1-year return | ~+17.6% | to 17 Sep 2026 | Anand Rathi |
6-month return | ~+46.7% | to 17 Sep 2026 | Anand Rathi |
3-year return | ~+172% | to 17 Sep 2026 | Anand Rathi |
5-year return | ~+155% | to 20 Mar 2026 | Univest |
Valuation Multiples
| Multiple | Aries Agro | Basis |
|---|---|---|
P/E (FY2026 EPS INR 32.95) | 14.6x | Price / EPS |
EV (market cap + net debt INR 7 cr) | ~INR 631 cr | — |
EV/EBITDA (FY2026 EBITDA INR 88.9 cr) | ~7.1x | — |
EV/Sales (FY2026 net revenue INR 740 cr) | ~0.85x | — |
P/B | ~2.0–2.2x | Depends on book-value basis |
Dividend yield (FY2026 total INR 2.50, if confirmed) | ~0.5% | — |
Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|
Dividend per share (INR) | 0.80 | 0.80 | 1.00 | 1.00 | 1.20 | 2.50 |
Dividend as % of face value | 8 | 8 | 10 | 10 | 12 | 25 |
Credit Ratings
| Agency | Rating | Outlook | Date | Facilities |
|---|---|---|---|---|
CRISIL Ratings | BBB+ (LT) / A2 (ST) | Positive | 27 May 2024 (reaffirmed Aug 2025 per Board's Report; current outlook n.v.) | INR 150 cr bank facilities |
CRISIL Ratings | BBB+ / A2 | Stable | 30 Mar 2023 | INR 150 cr |
CRISIL Ratings | BBB+ / A2 (assigned) | Stable | 11 Jan 2022 | INR 150 cr |
Brickwork Ratings | BWR BBB / A3+ | Stable | 8 Feb 2021 | INR 163.36 cr |
CARE Ratings | BBB- / A3 (reaffirmed and withdrawn) | Stable | 3 Dec 2020 | INR 175.05 cr |
Moody's / S&P / Fitch | Not rated | — | — | — |
Analyst Conclusions
Management guidance
No quantitative guidance is issued. Qualitatively, management (FY2026 and Q1 FY2027 press releases) expects to strengthen its growth trajectory on the back of distribution expansion, a diversified portfolio and research-driven solutions, while cautioning that results are inherently affected by seasonality, cropping patterns and weather.
Consensus expectations
No institutional consensus exists. For framing only: if FY2027 revenue grows in line with Q1 (+16%) to ~INR 860 cr at a stable ~5.7% net margin, PAT would be ~INR 49 cr (EPS ~INR 38), implying ~12.6x FY2027E P/E at the current price. This is an illustrative sensitivity, not a forecast.
Bull case
-
Structural re-rating of a de-risked business — net debt/EBITDA has fallen from 2.2x to 0.08x and ROE from ~6% to ~15%; at ~7x EV/EBITDA the stock still discounts the old, leveraged business.
-
Operating leverage on installed capacity — 28% unused capacity after the Sayakha addition allows growth without major capex, lifting FCF back toward the FY2025 level (~INR 74 cr).
-
Mix upgrade and adjacencies — HD/liquid formulations, crop-specific products and the fast-growing equipment subsidiary (+92%) can stabilise gross margin while broadening the addressable market.
Bear case
-
Gross-margin erosion is real — down ~260 bp over two years; if it continues while selling costs rise (brand ambassador, depots), operating leverage reverses.
-
Working-capital gains may be cyclical — receivable days fell sharply in a good agricultural year; a poor monsoon could reverse collections, as the company's 400–600-day CCC history shows.
-
Earnings quality and disclosure — FY2026 PBT growth benefited from ~INR 12.7 cr of other non-operating income; there are no earnings calls, segment detail or R&D disclosure, limiting institutional conviction and liquidity.
Catalysts and monitorables (next 12 months)
| Item | Expected timing | What to watch |
|---|---|---|
| Q2 FY2027 results | ~mid-Nov 2026 | Kharif-season revenue growth vs Q2 FY2026 (INR 200 cr); gross margin; receivables |
| Q3 FY2027 results | ~mid-Feb 2027 | Rabi demand; PAT run-rate |
| FY2027 annual booking disclosure | In FY2026 Annual Report / 2026 AGM materials | Growth over INR 830 cr |
| Monsoon 2027 forecast (IMD) | Apr–May 2027 | Sets FY2028 demand tone |
| FY2027 results and dividend | May 2027 | Sustained payout increase; special dividend repeat |
| Credit-rating review (CRISIL) | ~Aug 2027 | Possible upgrade to A- given deleveraging |
| Transmission of late director's ~20% stake | Any time | Promoter structure clarity |
| Amarak / UAE operations | Ongoing | Turnaround or impairment of ~INR 65 cr investments |
| Capacity utilisation | Ongoing | Movement above 72% |
| Institutional entry (MF/DII) | Ongoing | Shareholding filings |
Concluding analyst verdict
Aries Agro has spent most of its listed life as a classic "good franchise, poor economics" micro-cap: a genuine category pioneer in Indian chelated micronutrients whose returns were consumed by a bloated working-capital cycle, heavy trade discounting and interest costs. The evidence from FY2025 and FY2026 indicates a real, not cosmetic, change. Net debt has been almost eliminated, interest coverage has more than doubled to ~5x, receivable days have fallen to ~35, and ROE has roughly doubled to the mid-teens — all while revenue compounded at ~19–20% per year and capacity was expanded largely from internal cash. The Q1 FY2027 print (+16% revenue, +49% PAT) suggests momentum carried into the new year, and the board's decision to pay a special dividend signals confidence in cash generation.
The investment debate now shifts from balance-sheet survival to earnings quality and durability. Three issues matter most. First, gross margin has slipped every year since FY2024; the company must show that new HD and crop-specific products and the equipment business can arrest this. Second, the working-capital improvement has yet to be tested by a weak monsoon year; a reversal would quickly erode the re-rating. Third, disclosure is thin — no earnings calls, no product or regional splits, no R&D data — which constrains institutional ownership (mutual funds hold nothing) and keeps the stock illiquid.
At ~14.6x trailing earnings and ~7x EV/EBITDA, after a ~35% post-results rally, the valuation is no longer distressed but is undemanding for a near-debt-free, mid-teens-ROE specialty agri-input pure play if growth holds at mid-teens rates. The balance of evidence supports a constructive but monitored stance: the turnaround is substantiated by filings, but investors should require continued receivable discipline and gross-margin stabilisation through FY2027 before underwriting a further re-rating, and should treat any adverse monsoon as the principal downside trigger.
Principal sources: NSE/BSE Regulation 30 filings and iXBRL integrated financial results (13 Nov 2025; 28 May 2026; 11 Aug 2026); Aries Agro press releases (29 May 2026; 12 Aug 2026); Reg. 30 disclosures on Sayakha (12 Feb 2026) and Unnao (5 Mar 2026) units; FY2025 Board's Report and MD&A (via IIFL); AGM 2022 chairman's speech; CRISIL rating rationales (Aug 2017, Jan 2022, Mar 2023, May 2024); CARE releases (2018, 2019, Dec 2020); Brickwork rationale (Feb 2021); StockAnalysis, TipRanks, Screener, Tapetide, Anand Rathi, IIFL, Upstox, MarketsMojo, Emkay, BFSL, ScanX, PTI/HDFC Sky, Business News This Week, The Machine Maker, Global Agriculture (Oct 2026), Mordor Intelligence (via GII/DRI), IMARC Group, HTF MI, DivvyDiary, Zonebourse, Univest.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure / notes | Compensation (latest) |
|---|---|---|---|
Dr. Rahul Mirchandani | Chairman & Managing Director; largest promoter shareholder (28.67%) | Long-serving CMD (exact start n.v.); re-appointed MD for 5 years from 1 Apr 2027 (board 11 Aug 2026; AGM 29 Sep 2026). Recipient of a "CEO of the Year" award (date n.v.) | — |
Chhaya Ashok Warrier | CFO & Senior Vice President | n.v. | n.v. |
Qaiser P. Ansari | Company Secretary & Compliance Officer | Signatory on filings since at least 2018 | n.v. |
Board of Directors
| Director | Category | Notes |
|---|---|---|
Dr. Rahul Mirchandani | Chairman & MD (Executive, Promoter) | Combined Chair/CEO role |
Mrs. Nitya Mirchandani | Non-Executive, Non-Independent (Promoter group, 0.02%) | Director since at least 2018 |
Ramamurthy Sundaresan | Non-Executive, Non-Independent | Background n.v. |
Nrupang B. Dholakia | Independent Director | — |
R. V. Balasubramaniam Iyer | Independent Director | — |
Dr. Shailesh Ramesh Karnik | Independent Director | Appointed Additional Director (Independent) 13 Aug 2024 |
Board & Management Changes
| Date | Change |
|---|---|
13 Aug 2024 | Dr. Shailesh Ramesh Karnik appointed Independent Director |
26 Sep 2024 | Cessation of an independent director (name n.v.) |
Jan 2025 | Demise of Dr. Jimmy Mirchandani (Non-Executive Non-Independent Director) |
11 Aug 2026 | Board approved re-appointment of Dr. Rahul Mirchandani as MD for 5 years from 1 Apr 2027; AGM agenda also included re-appointment of an independent director |
Governance Detail
| Category | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Promoters and promoter group (%) | 52.66 | 52.66 | 52.66 | 52.66 |
Foreign institutional investors (%) | 3.20 | 2.91 | 3.25 | 3.13 |
Domestic institutions (%) | 0.00 | 0.00 | 0.00 | 0.02 |
Retail and others (%) | 44.14 | 44.43 | 44.09 | 44.19 |
Major Shareholders
| Holder | Shares | % |
|---|---|---|
Rahul Mirchandani | 3,728,275 | 28.67 |
Jimmy Mirchandani (estate) | 2,624,830 | 20.18 |
Akshay J. Mirchandani | 421,175 | 3.24 |
Amol Mirchandani | 70,646 | 0.54 |
Nitya Mirchandani | 3,000 | 0.02 |
Total promoter group | 6,847,926 | 52.66 |
Competitive Landscape
Key Competitors
| Competitor | Type | Overlap with Aries | Relative positioning |
|---|---|---|---|
Coromandel International Ltd | Diversified fertiliser and crop-protection major (Murugappa) | Micronutrients, secondary nutrients, water-soluble and specialty nutrients | Far larger scale and distribution; strong in South India |
Chambal Fertilisers & Chemicals Ltd | Urea/phosphate major | Micronutrients and specialty nutrients (traded) | Scale; listed by Mordor among top players |
Deepak Fertilisers & Petrochemicals Corp. Ltd | Fertiliser and chemicals (Mahadhan brand) | Specialty and water-soluble fertilisers | Strong in Maharashtra horticulture — direct overlap with Aries' core markets |
Indian Farmers Fertiliser Cooperative (IFFCO) | Cooperative | Micronutrients, water-soluble, nano-fertilisers | Cooperative reach; price competition |
Yara India (Yara International) | Multinational | Specialty and water-soluble nutrition, micronutrients | Premium global brand |
Mangalore Chemicals & Fertilizers Ltd | Fertiliser (Adventz group) | Micronutrients/specialty | Regional (Karnataka) |
UPL Ltd | Agrochemicals major | Micronutrients/biostimulants | Agri-input bundle; global |
Gujarat State Fertilizers & Chemicals Ltd | State fertiliser company | Specialty and water-soluble fertilisers | Gujarat stronghold |
Fertilizers & Chemicals Travancore Ltd | PSU fertiliser | Secondary/specialty nutrients | Kerala/South |
Madhya Bharat Agro Products Ltd | Small listed phosphate/sulphur fertiliser player | Sulphur and secondary nutrients | Closest listed small-cap peer by scale |
Grupa Azoty S.A. (Poland) | Multinational | Imported micronutrients | Cited by Mordor among top players |
Unorganised regional formulators | Local | Non-chelated sulphate micronutrients | Price-led; quality inconsistency |
Peer Comparison FY2025
| Metric | Aries Agro | Coromandel International | Chambal Fertilisers | Deepak Fertilisers |
|---|---|---|---|---|
Revenue (INR Cr) | 622 (FY2025); 740 (FY2026) | ~24,000 (approx., n.v. this session) | ~16,600 (approx., n.v.) | ~10,300 (approx., n.v.) |
Revenue growth FY2025 (%) | 20.5 | n.v. | n.v. | n.v. |
EBITDA margin (%) | 11.6 (net-revenue basis) | n.v. | n.v. | n.v. |
Net margin (%) | 5.4 | n.v. | n.v. | n.v. |
R&D intensity (%) | — | n.v. | n.v. | n.v. |
Business focus | Pure-play specialty micronutrients | Diversified | Primary nutrients dominant | Chemicals + fertilisers |
Recent Developments
Litigation, regulatory actions, layoffs or guidance revisions: none identified in the period.



